Oxford Immunotec Global PLC Announces Board Changes
March 08, 2021 at 04:36 pm EST
Oxford Immunotec Global PLC announced that on the effective Date, in connection with the Implementation Agreement and the Acquisition, each of the eight previous non-executive directors of the Company (Richard A. Sandberg, Ronald Andrews Jr., Patrick J. Balthrop Sr., Patricia Randall, Mark Klausner, Herman Rosenman, James R. Tobin, and A. Scott Walton) voluntarily resigned from the board of directors of the Company on the Scheme becoming effective. On the Effective Date, Joel Goldberg became a director of the Company, joining Peter Wrighton-Smith, Ph.D. on the board of directors of the Company.